Pharma News
Looking out for latest news on Pharma Magazine?
Check out the latest Pharma news, Top news in Pharma Magazine, Leading Magazine in Pharma industry. Daily news updates pertinent to the industrial sectors we are engaged with are depicted on the news section of Pharma industry which we operate.
Cellular Biomedicine Group Announces New Facility to Expand Research and Development and to Support Clinical Development
Thursday, October 03, 2019Cellular Biomedicine Group Inc a biopharmaceutical firm engaged in the drug development of immunotherapies for cancer and stem cell therapies for degenerative diseases today announced it has entered into a lease agreement to build an approximately s...
Xylyx Bio announces development of disease-specific cell culture products to accelerate anti-fibrotic drug discovery and screening
Thursday, October 03, 2019Xylyx Bio a pioneer in tissuespecific extracellular matrix biomaterials today announced the development of substrates for antifibrotic drug discovery as the next stage of its pipeline of preclinical cell culture products
Ocugen and CanSinoBIO Enter Strategic Partnership for Gene Therapy Co-Development and Manufacturing
Tuesday, October 01, 2019Ocugen Inc a clinical stage biopharmaceutical company focused on innovative therapies that address rare and underserved eye diseases has entered into a strategic partnership with CanSino Biologics CanSinoBIOHK on Ocugens gene therapy pipeline product...
Chimerix Announces Exclusive Global License Agreement with SymBio Pharmaceuticals for Brincidofovir
Tuesday, October 01, 2019Chimerix a developmentstage biopharmaceutical company dedicated to accelerating the advancement of innovative medicines that make a meaningful impact in the lives of patients living with cancer and other serious diseases today announces an exclusive...
Clover Biopharmaceuticals Doses First Patient in Phase I Study of SCB-313 in China for Malignant Ascites
Monday, September 30, 2019Clover Biopharmaceuticals a biotechnology company focused on developing novel and transformative biologic therapies today announced that the first patient was dosed in another Phase I trial of SCB an investigational fullyhuman TRAILTrimer fusion prot...
Currax™ Pharmaceuticals LLC Announces the Acquisition of Nalpropion Pharmaceuticals, Inc.
Monday, September 30, 2019Currax Pharmaceuticals LLC a specialty biopharmaceutical company with both Branded and generic business units announced today the acquisition of Nalpropion Pharmaceuticals As a result of this acquisition Currax now owns the worldwide rights to CONTRA...
Moderna Announces mRNA Immunotherapy Research Collaboration with Harvard University
Friday, September 27, 2019Moderna Inc a clinicalstage biotechnology company pioneering messenger RNA mRNA therapeutics and vaccines to create a new generation of transformative medicines for patients today announced a multiyear research collaboration with Harvard University w...
Catabasis Pharmaceuticals and the Jain Foundation Announce a Preclinical Research Collaboration to Study Edasalonexent in Dysferlinopathy
Friday, September 27, 2019Catabasis Pharmaceuticals Inc a clinicalstage biopharmaceutical company and the Jain Foundation a nonprofit foundation whose mission is to cure muscular dystrophies caused by dysferlin protein deficiency announced a preclinical research collaboration...
Blade Therapeutics Expands Anti-Fibrotic Pipeline With Acquisition of ATXCo and Its Autotaxin Inhibitor (PAT-409)
Thursday, September 26, 2019Blade Therapeutics a biopharmaceutical company advancing novel antifibrotic therapies today announced the acquisition of ATXCo Inc including its core asset PAT a Phase I ready autotaxin inhibitor for patients with fibrotic diseases
NeuCyte Licenses Promising Novel Compound for Treatment of Refractory Epilepsy and Related Neurological Disorders
Thursday, September 26, 2019NeuCyte Inc an innovative biotech company focused on developing novel treatments for neurological disorders today announced that it has entered into an exclusive license agreement with Trillium Therapeutics to advance an undisclosed preclinical compo...
